Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat

被引:13
作者
Falgarone, G
Blanchard, HS
Riot, B
Simonet, M
Breban, M
机构
[1] Hop Cochin, Inst Rheumatol, F-75674 Paris, France
[2] Hop Cochin, INSERM, U477, F-75674 Paris, France
[3] Univ Paris 05, Fac Necker, INSERM, U411, F-75730 Paris, France
[4] Inst Biol Lille, Dept Pathogenase Malad Infect & Parasitaires, F-59021 Lille, France
关键词
D O I
10.1128/IAI.67.8.3773-3779.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Yersinia-induced reactive arthritis is highly associated with HLA-B27, the role of which in defense against the triggering bacteria remains unclear. The aim of this study was to examine the capacity of rats transgenic for HLA-B27 to mount a cytotoxic T-lymphocyte (CTL) response against Y. pseudotuberculosis and to determine the influence of the HLA-B27 transgene on this response. Rats transgenic for HLA-B*2705 and human beta(2)-microglobulin of the 21-4L, line, which do not spontaneously develop disease, and nontransgenic syngeneic Lewis (LEW) rats were infected with Y. pseudotuberculosis. Lymph node cells were restimulated in vitro, and the presence of for Y. pseudotuberculosis-specific CTLs against infected targets was determined. Infection of 21-4L, rats triggered a CD8(+) T cell-mediated cytotoxic response specific for Y. pseudotuberculosis. Analysis of this response demonstrated restriction by an endogenous major histocompatibility complex molecule. However, no restriction by HLA-B27 was detected. In addition, kinetics studies revealed a weaker anti-Yersinia CTL response in 21-4L rats than in nontransgenic LEW rats, and the level of cytotoxicity against 21-4L, lymphoblast targets sensitized with Y. pseudotuberculosis was lower than that against nontransgenic LEW targets. We conclude that HLA-B27 transgenic rats mount a CTL response against Y. pseudotuberculosis that is not restricted by HLA-B27. Yet, HLA-B27 exerts a negative effect on the level of this response, which could contribute to impaired defense against Yersinia.
引用
收藏
页码:3773 / 3779
页数:7
相关论文
共 57 条
  • [1] HL-A 27 IN REACTIVE ARTHRITIS - STUDY OF YERSINIA ARTHRITIS AND REITERS DISEASE
    AHO, K
    AHVONEN, P
    LASSUS, A
    SIEVERS, K
    TIILIKAINEN, A
    [J]. ARTHRITIS AND RHEUMATISM, 1974, 17 (05): : 521 - 526
  • [2] Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: An ultrastructural and histological study
    Autenrieth, IB
    Firsching, R
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 44 (04) : 285 - 294
  • [3] EXPERIMENTAL YERSINIA-ENTEROCOLITICA INFECTION IN EUTHYMIC AND T-CELL-DEFICIENT ATHYMIC NUDE C57BL/6 MICE - COMPARISON OF TIME-COURSE, HISTOMORPHOLOGY, AND IMMUNE-RESPONSE
    AUTENRIETH, IB
    VOGEL, U
    PREGER, S
    HEYMER, B
    HEESEMANN, J
    [J]. INFECTION AND IMMUNITY, 1993, 61 (06) : 2585 - 2595
  • [4] LYMPHOCYTES-T MEDIATE PROTECTION AGAINST YERSINIA-ENTEROCOLITICA IN MICE - CHARACTERIZATION OF MURINE T-CELL CLONES SPECIFIC FOR Y-ENTEROCOLITICA
    AUTENRIETH, IB
    TINGLE, A
    RESKEKUNZ, A
    HEESEMANN, J
    [J]. INFECTION AND IMMUNITY, 1992, 60 (03) : 1140 - 1149
  • [5] Boisgérault F, 1998, INFECT IMMUN, V66, P4484
  • [6] Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants - Implications for susceptibility to spondylarthropathies
    Boisgerault, F
    Tieng, V
    Stolzenberg, MC
    Dulphy, N
    Khalil, I
    Tamouza, R
    Charron, D
    Toubert, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) : 2764 - 2770
  • [7] BOLIN I, 1982, INFECT IMMUN, V37, P506
  • [8] THE PLASMID-ENCODED YOP2B PROTEIN OF YERSINIA-PSEUDOTUBERCULOSIS IS A VIRULENCE DETERMINANT REGULATED BY CALCIUM AND TEMPERATURE AT THE LEVEL OF TRANSCRIPTION
    BOLIN, I
    WOLFWATZ, H
    [J]. MOLECULAR MICROBIOLOGY, 1988, 2 (02) : 237 - 245
  • [9] BURMESTER GR, 1995, ANNU REV IMMUNOL, V13, P229, DOI 10.1146/annurev.iy.13.040195.001305
  • [10] YERSINIA IN INTESTINAL BIOPSY SPECIMENS FROM PATIENTS WITH SERONEGATIVE SPONDYLOARTHROPATHY - CORRELATION WITH SPECIFIC SERUM IGA ANTIBODIES
    DEKONING, J
    HEESEMANN, J
    HOOGKAMPKORSTANJE, JAA
    FESTEN, JJM
    HOUTMAN, PM
    VANOIJEN, PLM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) : 109 - 112